Abstract:Introduction: The Rho family GTPase Rac1 regulates cytoskeletal rearrangements crucial for the recruitment, extravasation and activation of leukocytes at sites of inflammation. Rac1 signaling also promotes the activation and survival of lymphocytes and osteoclasts. Therefore, we assessed the ability of a cell-permeable Rac1 carboxy-terminal inhibitory peptide to modulate disease in mice with collagen-induced arthritis (CIA). Methods: CIA was induced in DBA/1 mice, and in either early or chronic disease, mice were treated three times per week by intraperitoneal injection with control peptide or Rac1 inhibitory peptide. Effects on disease progression were assessed by measurement of paw swelling. Inflammation and joint destruction were examined by histology and radiology. Serum levels of anti-collagen type II antibodies were measured by enzyme-linked immunosorbent assay. Tcell phenotypes and activation were assessed by fluorescence-activated cell sorting analysis. Results were analyzed using Mann-Whitney U and unpaired Student t tests. Results: Treatment of mice with Rac1 inhibitory peptide resulted in a decrease in paw swelling in early disease and to a lesser extent in more chronic arthritis. Of interest, while joint destruction was unaffected by Rac1 inhibitory peptide, anti-collagen type II antibody production was significantly diminished in treated mice, in both early and chronic arthritis. Ex vivo, Rac1 inhibitory peptide suppressed T-cell receptor/CD28-dependent production of tumor necrosis factor α, interferon γ and interleukin-17 by T cells from collagen-primed mice, and reduced induction of ICOS and CD154, T-cell costimulatory proteins important for B-cell help. Conclusions: The data suggest that targeting of Rac1 with the Rac1 carboxy-terminal inhibitory peptide may suppress T-cell activation and autoantibody production in autoimmune disease. Whether this could translate into clinically meaningful improvement remains to be shown. Introduction Rheumatoid arthritis (RA) is marked by de-regulated recruitment, activation, and retention of inflammatory white blood cells in affected joints [1]. Subsequent autoantibody production, release of cytokines, and cell-cell contacts may perpetuate inflammation and lead to joint destruction through activation of stromal fibroblast-like synoviocytes (FLSs) and osteoclasts [2]. Many of the cellular processes required for perpetuation of inflammation and joint destruction in RA are regulated by Rac GTPases, members of the Rho-like family of small GTPase signaling proteins [3]. Rac1 is ubiquitously expressed in mammalian tissues, whereas expression of Rac2 is limited to cells of hematopoietic lineage [4,5]. Rac GTPases are activated by a broad array of extracellular stimuli relevant to RA, * Correspondence: p.p.tak@amc.uva.nl 1Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, Amsterdam, 1105 AZ, The

Multifactorial Analysis of Noc Lung Carcinoma Radiotherapy

articleA Rac 1 inhibitory peptide suppresses antibody production and paw swelling in the murine collagen-induced arthritis model of rheumatoid arthritis

[Radiologic diagnosis of the retroperitoneal masses (author's transl)].

Swine industry stakeholders' perception on the use of water-based foam as an emergency mass depopulation method

Safety and efficacy of a feed additive consisting of Weizmannia faecalis DSM 32016 (TechnoSpore50®) for poultry for fattening, poultry reared for laying/breeding, ornamental birds and suckling and weaned Suidae piglets (Biochem Zusatzstoffe Handels- und Produktionsgesellschaft GmbH)

London 2012: Olympic Risk, Risk Management, and Olymponomics

Safety and efficacy of a feed additive consisting of Pediococcus acidilactici CNCM I-4622 for all insect species (Danstar Ferment AG)

Re‐evaluation of polyvinylpyrrolidone (E 1201) and polyvinylpolypyrrolidone (E 1202) as food additives and extension of use of polyvinylpyrrolidone (E 1201)

EMA and EFSA Joint Scientific Opinion on measures to reduce the need to use antimicrobial agents in animal husbandry in the European Union, and the resulting impacts on food safety (RONAFA)

Safety and efficacy of a feed additive consisting of a preparation of carvacrol, thymol, d‐carvone, methyl salicylate and l‐menthol (Biomin® DC‐P) for all poultry species (Biomin GmbH)

Mother-to-child transmission of human immunodeficiency virus (HIV) among HIV-infected pregnant women on highly active anti-retroviral therapy with premature rupture of membranes at term

Safety and efficacy of a feed additive consisting of sodium bisulphate for all animal species except aquatic animals (Grillo Werke AG & Jones‐Hamilton Co.)

Assessment of the feed additive consisting of Pediococcus pentosaceus DSM 14021 for all animal species for the renewal of its authorisation (Chr. Hansen A/S)

Safety and efficacy of a feed additive consisting of an essential oil obtained from the fruit of Apium graveolens L. (celery seed oil) for all animal species (FEFANA asbl)

Safety of Acheta domesticus powder as a Novel food pursuant to Regulation (EU) 2015/2283

Safety of partially defatted house cricket (Acheta domesticus) powder as a novel food pursuant to Regulation (EU) 2015/2283

Comparative Analysis of Animal Welfare in Three Broiler Slaughterhouses and Associated Farms with Unsatisfactory Slaughterhouse Results

Safety and efficacy of propyl gallate for all animal species

Humane Slaughter of Edible Decapod Crustaceans